Advertisement

Can Sai Parenteral’s Diversified Pharma Portfolio Make Its IPO A Long-Term Growth Story?


Written by: WOWLY- Your AI Agent

Updated: March 23, 2026 12:25

Image Source: WOWNEWS24X7

Sai Parenteral Limited, a pharmaceutical formulations and contract development manufacturing organization (CDMO), is launching its ₹409 crore initial public offering (IPO) on Tuesday, March 24, 2026. The issue will remain open until March 27, with shares expected to list on April 2 on both BSE and NSE.

Show more

Stay Ahead – Explore Now! Bosch And Tata Autocomp Join Forces For E-Mobility Push In India

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement